TENX

TENAX THERAPEUTICS, INC. TENX

NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Below size threshold

Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $1.9M in revenue and is scored on the micro-cap board instead.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Revenue

$0

Quarter to Jun 30

Net income

$-17.80M

Quarter to Jun 30

Top Institutional Holders

as of Q2 2026
$441.43M total
FMR LLC
$57.36M+1122.1%
Vivo Capital, LLC
$36.38M+1100.0%
BlackRock, Inc.
$25.14MNew
PERCEPTIVE ADVISORS LLC
$24.73M+17.4%
VANGUARD CAPITAL MANAGEMENT LLC
$16.69M+335.5%
MILLENNIUM MANAGEMENT LLC
$12.75M+64.1%
Ikarian Capital, LLC
$11.46M-22.6%
Candriam S.C.A.
$10.90MNew
CITADEL ADVISORS LLC
$10.60M+377.7%
RTW INVESTMENTS, LP
$10.14M+88.1%
Stonepine Capital Management, LLC
$9.60M-32.3%
GEODE CAPITAL MANAGEMENT, LLC
$9.31M+824.7%
PRICE T ROWE ASSOCIATES INC /MD/
$8.84M-79.4%
MARSHALL WACE, LLP
$8.52M+66.1%
BRAIDWELL LP
$8.50MNew
Point72 Asset Management, L.P.
$8.10M+4.3%
Velan Capital Investment Management LP
$8.00M-5.7%
ADAGE CAPITAL PARTNERS GP, L.L.C.
$7.86M0.0%
Woodline Partners LP
$7.73M+64.0%
STATE STREET CORP
$7.43M+1662.0%
Sofinnova Ventures Inc
$7.28M+379.0%
Jupiter Topco LLC
$6.57M--
MORGAN STANLEY
$6.29M-27.5%
Qube Research & Technologies Ltd
$6.25M+1419.9%
Siren, L.L.C.
$6.21M0.0%
See all 112 institutional holders →
Reading the latest SEC filing…

Key Metrics

Revenue

Q2 2026
EDGAR

Net Income

Q2 2026
EDGAR

EPS (Diluted)

Q2 2026
EDGAR

ROIC

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/TENX

Earnings Per Share

13fpro.ai/company/TENX

Loading ratio trend…

TENX key financials by period

Reported revenue, net income and operating margin by fiscal year, from TENAX THERAPEUTICS, INC.'s annual filings on SEC EDGAR.

TENAX THERAPEUTICS, INC. reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodRevenueNet incomeOp. margin
FY 2015$49.3K$-14.1M—
FY 2014$158.9K$-19.5M—
FY 2013$1.2M$-9.4M—
FY 2012$363.8K$-15.7M—
FY 2011$103.2K$10.4M—
Source: TENX filings on SEC EDGAR →

TENX insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About TENAX THERAPEUTICS, INC. (TENX): stock profile, AI score and financials

TENAX THERAPEUTICS, INC. (TENX) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. TENX is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $1.9m in revenue and is scored on the micro-cap board instead. Top institutional holders of TENX by reported 13-F value include FMR, Vivo Capital, BlackRock, based on the most recent SEC filings. TENX trades on the Nasdaq exchange and files with the SEC under CIK 34956. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate TENX daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for TENAX THERAPEUTICS, INC. directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 34956 →